None listed
Conditions
Brief summary
Almost a decade ago, the SAFE study provided information on the effect of saline and albumin resuscitation fluids in adult patients in intensive care. Despite further studies, there remains a paucity of data on the most appropriate resuscitation fluid in infants and children in intensive care. The SAFE Extrapolation to Paediatric Intensive Care (SAFE-EPIC) study is an international point prevalence study of fluid resuscitation practice in paediatric patients in intensive care. The SAFE-EPIC study aims to describe the type of fluid used and the patient and intensive care unit factors associated with the use of this fluid in paediatric patients (0 – 16 years) in registered intensive care sites in countries throughout the world on two study dates (one in December 2012, and one in July 2013).
Interventions
Observation of type, volume and rate of resuscitation fluid administration and description of unit and patient factors in infants and children receiving a fluid resuscitation on the study day. All infants and children in participating intensive care units will be studied on each of two study dates (one in December 2012, and one in July 2013).
Sponsors
Dr Marino Festa
Eligibility
Sex/Gender
All
Age
0 to 16 Years
Healthy volunteers
No
Inclusion criteria
All newborns, infants or children aged 0 to 16 years (inclusive) in a participating intensive care unit at 12:00 midday on the study days.
Exclusion criteria
Age 17 years or more
Outcome results
None listed